Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-16-108186

Options or other derivatives

  • CMO; Senior VP Clinical Dev. acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SHREWSBURY STEPHEN B · CMO; Senior VP Clinical Dev.

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-03-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +35,000 35,000 D
Loading xslF345X03/doc4.xml…